OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
(+)-gallocatechin-(4alpha->8)-(+)-catechin
(2S)-2-[(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-4,4,7,8a-tetramethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrouro[2,3-e]isoindole]-7'-yl]-4-methylpentanoic acid
3-hydroxy-4-(4-hydroxy-3-methoxyphenyl)butan-2-one
6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene
Bacilotetrin B
cefbuperazone
Crinipellin A
Deoxycorticosterone 21-glucoside
Deoxynivalenol 3-glucoside
Gageopeptide D
N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3S,4S,5R,6R)-4-[(2S,3S,4S,5R,6R)-3-[(2R,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-[(2S,3R,4R,5S,6R)-3-acetamido-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
octreotide
PG(44:10)
PI(O-18:0/20:3(8Z,11Z,14Z))
SMS 201-995
CL: Cell Ontology
skeletal muscle satellite cell
EFO: Experimental Factor Ontology
Smith-Magenis syndrome
smoothelin
smoothelin (human)
SMS (human)
SMS-KCN
somatostatin
somatostatin receptor type 1
spermine synthase
spermine synthase (human)
spermine synthase, initiator methionine removed form
Stiff-Person syndrome
GO: Molecular Function
sphingomyelin synthase activity
RDO: RGD Disease Ontology
Smith-Magenis syndrome
syndromic X-linked intellectual disability Snyder type
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||



















